Higher Semaglutide Dose Safe, Boosts Weight Loss: Study
New Delhi, 15 Sep 2025 (Punjab Khabarnama Bureau): A landmark clinical study has revealed that higher doses of semaglutide, a widely used GLP-1 receptor agonist, are safe and lead to…
New Delhi, 15 Sep 2025 (Punjab Khabarnama Bureau): A landmark clinical study has revealed that higher doses of semaglutide, a widely used GLP-1 receptor agonist, are safe and lead to…